Publicacións (28) Publicacións de Francisco José Maceiras Pan

filter_list

2025

  1. Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

    Rheumatology, Vol. 64, Núm. 6, pp. 3733-3738

  2. Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: Insights from the ARTESER registry

    Rheumatology, Vol. 64, Núm. 9, pp. 4985-4994

  3. Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  4. Visual manifestations in giant cell arteritis: Identification of risk factors from the ARTESER Registry

    Rheumatology, Vol. 64, Núm. 2, pp. 697-703

2024

  1. Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice

    Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31

  2. Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner

    Frontiers in Immunology, Vol. 14

  3. The activity of psoriatic arthritis with axial involvement correlates with the PsAID12

    Reumatologia Clinica, Vol. 20, Núm. 2, pp. 80-83

2022

  1. Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology

    BMC Health Services Research, Vol. 22, Núm. 1

2021

  1. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745

  2. Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia

    Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154

  3. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50

  4. Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice

    Reumatologia Clinica, Vol. 17, Núm. 4, pp. 203-206

2020

  1. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project

    Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31

  2. Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review

    Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 324-332

  3. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study

    Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 116-119

2019

  1. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

  2. Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab

    Medicine, Vol. 98, Núm. 26, pp. e15947

  3. Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257

2017

  1. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430

2006

  1. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145